卡铂
医学
化疗
紫杉醇
血液透析
内科学
肿瘤科
癌
泌尿科
透析
外科
顺铂
作者
Hitoshi Niikura,Toshimitsu Koizumi,Kiyoshi Ito,Kunihiro Okamura,Nobuo Yaegashi
出处
期刊:Anti-Cancer Drugs
[Lippincott Williams & Wilkins]
日期:2003-10-01
卷期号:14 (9): 735-738
被引量:12
标识
DOI:10.1097/00001813-200310000-00008
摘要
We report on three cases of long-term dialysis patients with gynecological malignancies who were successfully treated with chemotherapy. Two epithelial ovarian carcinoma patients were treated with a single agent, carboplatin (100-200 mg/m2). One recurrent endometrial carcinoma patient was treated with carboplatin (200 mg/m2) and paclitaxel (135 mg/m2). Hemodialysis was started 2 h after the carboplatin infusion and lasted 4 h in all three cases. All patients tolerated these therapies without significant myelosuppression or severe side-effects. Our findings suggest these regimens are feasible, and the combination of paclitaxel and carboplatin is effective chemotherapy when administered to long-term hemodialysis patients with recurrent endometrial carcinoma.
科研通智能强力驱动
Strongly Powered by AbleSci AI